Title : Treatment of breast cancer in countries with limited resources.

Pub. Date : 2003 May-Jun

PMID : 12713499






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In postmenopausal women with ER- and/or progesterone receptor (PR)-positive or PR-unknown breast cancer, the use of tamoxifen or anastrozole is effective adjuvant endocrine therapy. Anastrozole estrogen receptor 1 Homo sapiens
2 In postmenopausal women with ER- and/or progesterone receptor (PR)-positive or PR-unknown breast cancer, the use of tamoxifen or anastrozole is effective adjuvant endocrine therapy. Anastrozole progesterone receptor Homo sapiens
3 In postmenopausal women with ER- and/or progesterone receptor (PR)-positive or PR-unknown breast cancer, the use of tamoxifen or anastrozole is effective adjuvant endocrine therapy. Anastrozole progesterone receptor Homo sapiens
4 In postmenopausal women with ER- and/or progesterone receptor (PR)-positive or PR-unknown breast cancer, the use of tamoxifen or anastrozole is effective adjuvant endocrine therapy. Anastrozole progesterone receptor Homo sapiens